ロード中...
Assessing bias in administrative database studies of RotaTeq vaccine completion due to exclusion of subjects with incomplete follow-up
BACKGROUND: RotaTeq® pentavalent human rotavirus vaccine (RV5) is effective against rotavirus illness and rotavirus-related hospitalizations and death. Effectiveness depends on adherence to the dosing schedule, which includes 3 doses at ages 2, 4 and 6 months. Two studies have used automated claims...
保存先:
| 出版年: | Emerg Themes Epidemiol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406204/ https://ncbi.nlm.nih.gov/pubmed/25904968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12982-015-0027-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|